Integer Holdings CorpITGR

時価総額

$25.1億

PER

医療機器向け受託開発・製造の最大手。心血管・神経領域のカテーテルや植込み機器の部品・完成品製造を展開。2024年1月の微細加工企業買収（1.423億ドル）。米国中心に15拠点、欧州・メキシコ・アジア展開。

	2011年 12月30日	2012年 12月28日	2014年 1月3日	2015年 1月2日	2016年 1月1日	2016年 12月30日	2017年 12月29日	2018年 12月28日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net income	33	-5	36	55	-8	6	67	168	96	77	97	66	91	120
Depreciation and amortization	48	46	36	37	45	91	103	89	78	79	81	92	99	111
Debt related charges included in interest expense	-	13	6	1	11	7	11	49	8	5	7	2	8	4
Inventory Write-down	-	-	-	-	-	-	-	-	-	-	-	1	1	1
Stock-based compensation	12	11	14	13	9	8	15	10	9	9	16	21	23	25
Non-cash lease expense	-	-	-	-	-	-	-	-	-	-	-	11	11	9
Non-cash loss on equity investments	-	-	-	-	-	-	-	-	-0	5	-3	-8	-6	-1
Contingent consideration fair value adjustment	-	-	-	-	-	-	-	-	-	2	-0	-3	1	4
Other non-cash losses	1	-	-	-	-	-	-	-	-	-1	-2	-6	-4	-7
Deferred income taxes	9	6	-30	1	-10	-7	-59	61	-10	-7	-11	-17	-9	-14
Gain on sale of discontinued operations	-	-	-	-	-	-	-	195	5	-	-	-	-	0
Accounts receivable	13	19	-7	12	-4	2	35	-9	7	-38	18	41	7	7
Inventories	2	7	12	7	26	-22	1	16	-4	-18	-5	57	30	18
Contract assets	-	-	-	-	-	-	-	-	-	16	25	8	14	18
Prepaid expenses and other assets	1	-1	0	3	2	4	-5	-9	31	1	2	-1	1	0
Accounts payable	4	6	1	-1	3	-1	5	-0	2	-9	20	26	-1	-17
Accrued expenses and other liabilities	4	1	-1	1	-29	-14	15	-12	-3	-11	-23	-10	8	4
Income taxes payable	1	1	-3	3	-10	-7	14	0	-5	-4	-4	13	-7	1
Net cash provided by operating activities	90	65	57	81	12	106	149	167	165	181	157	116	180	205
Acquisition of property, plant and equipment	22	41	19	25	45	59	47	45	48	47	53	75	120	105
Purchase of intangible asset	-	-	-	-	-	-	-	-	-	5	-	-	-	0
Proceeds from sale of property, plant and equipment	0	0	0	-	1	0	0	1	0	0	0	1	0	0
Proceeds from return of capital from equity investments	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Acquisitions, net of cash acquired	66	17	-	16	423	-	-	-	15	5	218	127	44	139
Proceeds from sale of discontinued operations, net	-	-	5	3	-	-	-	-	-	-	-	-	-	49
Net cash used in investing activities	-80	-60	-18	-36	-474	-63	-48	537	-59	-57	-271	-200	-163	-195
Principal payments of long-term debt	-	-	-	-	-	-	-	-	-	-	-	-	416	0
Proceeds from Issuance of Long-Term Debt	45	10	425	-	1,750	57	50	5	-	-	818	-	-	-
Proceeds from Secured Lines of Credit	-	-	-	-	-	-	-	-	-	-	82	166	383	275
Payments of revolving credit facility	-	-	-	-	-	-	-	-	-	-	-	-	425	248
Purchase of capped calls	-	-	-	-	-	-	-	-	-	-	-	-	35	-
Payment of debt issuance costs	2	-	3	-	46	1	2	32	1	1	8	-	2	2
Proceeds from Stock Options Exercised	-	-	-	-	-	-	19	12	3	3	1	0	2	1
Tax withholdings related to net share settlements of restricted stock units	-	-	-	-	-	-	-	5	3	4	5	3	3	11
Proceeds from contingent consideration	-	-	-	-	-	-	-	-	-	-	-	1	-	-
Payment of contingent consideration	-	-	-	-	-	-	-	-	-	-	2	1	8	-
Principal payments on finance leases	-	-	-	-	-	-	-	-	-	0	0	1	1	11
Other financing activities	-1	-1	-0	-1	-0	-2	-0	-	-	-	-	-	-	9
Net cash provided by (used in) financing activities	4	-21	-23	-2	468	-72	-112	-725	-118	-89	82	92	-18	13
Effect of foreign currency exchange rates on cash and cash equivalents	-	-	-	-	-	-	-	-	-1	-1	1	-2	1	-0
Net increase (decrease) in cash and cash equivalents	-	-	-	-	-	-	-	-	-12	36	-31	6	-1	23